PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
100 hedge funds and large institutions have $284M invested in Provention Bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 47 increasing their positions, 28 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
6% less funds holding
Funds holding: 106 → 100 (-6)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
Holders
100
Holding in Top 10
1
Calls
$5.1M
Puts
$1.99M
Top Buyers
| 1 | +$11.5M | |
| 2 | +$6.13M | |
| 3 | +$5.5M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$4.88M |
| 5 |
Two Sigma Investments
New York
|
+$4.88M |
Top Sellers
| 1 | -$7.33M | |
| 2 | -$7.06M | |
| 3 | -$3.53M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$3.34M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$2.48M |